Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.
Quraishi MN, Cheesbrough J, Rimmer P, Mullish BH, Sharma N, Efstathiou E, Acharjee A, Gkoutus G, Patel A, Marchesi JR, Camuzeaux S, Chappell K, Valdivia-Garcia MA, Ferguson J, Brookes M, Walmsley M, Rossiter A, van Schaik W, McInnes RS, Cooney R, Trauner M, Beggs A, Iqbal T, Trivedi PJ.
Quraishi MN, et al. Among authors: van schaik w.
J Crohns Colitis. 2024 Dec 14:jjae189. doi: 10.1093/ecco-jcc/jjae189. Online ahead of print.
J Crohns Colitis. 2024.
PMID: 39673746